VERDICT
We value your privacy - bamsec.com
Depends. Buy if you're a professional or serious investor who digests SEC filings daily and will actually use the tables, transcripts, and screening. Skip if you're a casual investor — free EDGAR plus a spreadsheet covers you, and there's no trial to test first.
Medium. Based on 15 public sources: Reddit and forum threads, pricing directories, vendor pages, and acquisition news.
$35/month
Basic
medium
No free trial — you pay before testing anything
medium
Individual plan value is actively debated; only heavy filings users clearly win
medium
Exporting numbers is clunky; users built workaround tools to avoid pasting
low
Post-acquisition, features may shift toward AlphaSense bundling or integration
Value for money: 3/5
Rating
$35/month
Starting price
15
Sources
Analyzed
$35/month
Not published in sources
No known vulnerabilities found in the sources reviewed.
Users find it genuinely useful for filings research but frequently hunt for cheaper or free alternatives.
“Got sick of pasting numbers from BamSEC, made a tool to ...”
“Buying a BamSEC Individual account or other platform worth it? recommendations”
“Is there a free resource”
Compare BamSEC with each alternative.
Free official filings; enough for casual research
Cheaper all-rounder with dashboards and transcripts
BamSEC vs KoyfinForensic-research focus; positioned as BamSEC alternative
BamSEC vs Hudson LabsReal-time filing news; compared head-to-head with BamSEC
BamSEC vs StockTitanBased on 15 public sources: Reddit and forum threads, pricing directories, vendor pages, and acquisition news.
Solid SEC filings + transcript research for pros; no free trial, and casual investors can stick with free EDGAR.
Based on 15 public sources: Reddit and forum threads, pricing directories, vendor pages, and acquisition news.
Anonymous. You can change your vote.
Loading votes…
Comments
One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.
No comments yet.